Generate a tailored SOP for Dr. Julie Blendy. Improve your application with a focused, well-structured draft.
Julie Blendy is a Professor in the Department of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania's Perelman School of Medicine. Her research focuses on the molecular basis of addiction and depression, aiming to understand the biochemical and behavioral changes associated with chronic drug use. Blendy's work employs a range of research techniques, including gene targeting for mouse model generation and behavioral analysis, to investigate the transcriptional response of specific proteins involved in central nervous system adaptations due to drug exposure. Her group has identified crucial transcription factors, such as CREB and CREM, and their roles in the response to elevated levels of cAMP in the context of addiction and mood disorders. Blendy's research also explores the comorbidity of addiction and depression, seeking to unravel the underlying molecular mechanisms that contribute to these interconnected conditions.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.